MedPath

IONETIX CORPORATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
https://www.ionetix.com/

Clinical Trials

1

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

FDA:1

Drug Approvals

Ammonia N 13

Approval Date
Mar 15, 2024
FDA

Clinical Trials

Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)

Recruiting
Conditions
Coronary Disease
Heart Diseases
Myocardial Ischemia
Arterial Occlusive Diseases
Coronary Artery Disease
Arteriosclerosis
Cardiovascular Diseases
Vascular Diseases
Interventions
Diagnostic Test: Myocardial Perfusion Imaging Study
First Posted Date
2020-04-13
Last Posted Date
2023-07-07
Lead Sponsor
Ionetix Corporation
Target Recruit Count
2500
Registration Number
NCT04343209
Locations
🇺🇸

Doral Imaging Institute, LLC DBA CIRA Miami Beach, Miami Beach, Florida, United States

🇺🇸

Doral Imaging Institute, LLC dba CIRA, Miami, Florida, United States

🇺🇸

Adler Institute for Advanced Imaging, Jenkintown, Pennsylvania, United States

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.